Oxlumo (Lumasiran 94.5 MG/0.5 mL)

Oxlumo (lumasiran) is an HAO1-directed small interfering ribonucleic acid (siRNA) used for the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary and plasma oxalate levels in pediatric and adult patients.
.
Recommended Dosage:
The recommended dosage regimen of Oxlumo is typically administered through subcutaneous (SC) injections. Treatment starts with a loading phase followed by a maintenance phase. The loading phase involves a series of monthly doses designed to quickly reduce the level of oxalate in the body. After completing the loading phase, maintenance doses are continued on a regular schedule to help sustain reduced oxalate production over time. This two-step regimen ensures that patients with primary hyperoxaluria type 1 receive effective and ongoing management of their condition. Treatment must be guided and monitored by a healthcare professional (HCP) for the best results.

If a dose is delayed or missed, administer it as quickly as possible. Resume prescribed monthly or quarterly dosing, from the most recently administered dose.

• Use Lumasiran during pregnancy only if urgently required. Limited human data exist. Animal studies did not indicate harm to the baby, but it’s best to consult your doctor to weigh the benefits and possible risks before use during pregnancy.
• It is not known whether Lumasiran passes into breast milk. Mothers using Lumasiran should talk to their healthcare provider. A decision should be made whether to stop breastfeeding or stop the medication, based on the baby’s health and the mother’s treatment needs.
• Lumasiran 94.5 mg/0.5 mL is approved for use in children of all ages with primary hyperoxaluria type 1. However, the dosage may fluctuate by age or weight. Parents must follow the doctor’s words very carefully to ensure the child receives the correct dose and undergo regular monitoring.
• There is limited clinical data on the use of this drug in patients aged 65 and older. No major differences in effectiveness or safety have been noticed, but older individuals must be monitored closely for any side effects or changes in kidney function.
• The effect of liver disease on this treatment has not been completely studied. Patients with liver impairment must use it with caution. Clinicians may consider dose adjustments or more frequent monitoring to avoid undesired reactions or accumulation of the medicine in the body.
• This therapeutic drug can be used in individuals with kidney complications, including those with advanced renal disease. However, dose changes may be required in serious cases. Regular monitoring of kidney function is essential to ensure the safety and continued effectiveness of the treatment.

What documents are required to import OXLUMO to India?

OXLUMO (lumasiran) injections can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is OXLUMO available in India?

OXLUMO (lumasiran injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Oxlumo in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

OXLUMO can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of OXLUMO (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Oxlumo 94.5 mg/0.5 mL injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source OXLUMO (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Oxlumo®?

Lumasiran is the Generic Name for the trade name drug Oxlumo®.

What is the Manufacturer’s Name of Oxlumo®?

Oxlumo® is manufactured by Alnylam Pharmaceuticals, Inc.

Is Oxlumo® approved by the FDA?

Yes, Oxlumo® is approved by the FDA. Date of first approval: November 23, 2020.

What is the dosage and form of Oxlumo® supplied?

Oxlumo is supplied Injection: 94.5 mg/0.5 mL in a single-dose vial for subcutaneous (SC) use.

What are the most common side effects of Oxlumo® 94.5 mg/0.5 mL injection?

The most common side effects of Oxlumo® are pneumonia, respiratory distress, catheter-related infection, respiratory failure, respiratory syncytial virus infection, fever, and gastroenteritis.

How much does Oxlumo® 94.5 mg/0.5 mL injection cost in India?

Oxlumo® is not yet approved in India. However, patients in India can legally access it through the provision Named Patient Program (NPP). Prices of Oxlumo injections may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Oxlumo 94.5 mg/0.5 mL cost in India, please call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Oxlumo® 94.5 mg/0.5 mL injections be available in SAARC countries?

Apart from Gulf countries, Oxlumo® can be accessed through import provisions like Named Patient Import in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Oxlumo® injection in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Oxlumo® 94.5 mg/0.5 mL injection online in India?

Yes, one can buy Oxlumo 94.5 mg/0.5 mL online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of this therapeutic drug through legal channels.

What are the storage conditions of Oxlumo® 94.5 mg/0.5 mL injections?

Store this therapeutic drug at 2 to 25°C [36 to 77°F]. Store the vials in its original container until ready for use.